The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Assessment of circulating free DNA concentration as a prognostic and predictive biomarker in a large cohort of non-small cell lung cancer treated by platinum-based chemotherapy.
 
Claire Tissot
No Relationships to Disclose
 
Anne Claire Toffart
Honoraria - Boehringer Ingelheim; Lilly
Travel, Accommodations, Expenses - Boehringer Ingelheim; Lilly; Roche Pharma AG
 
Stephanie Villar
No Relationships to Disclose
 
Pierre Jean Souquet
Honoraria - AstraZeneca; Bristol-Myers Squibb; Roche
Consulting or Advisory Role - Lilly/ImClone; PFIZER; Roche/Genentech
Speakers' Bureau - Amgen; AstraZeneca; boehringer ingelheim; Lilly/ImClone; pfizer; Roche/Genentech
Research Funding - AstraZeneca; Boehringer Ingelheim; Clovis Oncology; GlaxoSmithKline; LILLY (Inst); Novartis; Roche/Genentech (Inst)
Travel, Accommodations, Expenses - LILLY; PFIZER
 
Patrick Merle
No Relationships to Disclose
 
Denis Moro-Sibilot
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Lilly/ImClone; Novartis; Pfizer; Roche/Genentech; Sanofi
Travel, Accommodations, Expenses - Lilly/ImClone; Pfizer; Roche/Genentech
 
Maurice Pérol
Honoraria - Lilly; Pierre Fabre; Roche Pharma AG
Consulting or Advisory Role - Lilly; Pierre Fabre; Roche Pharma AG
Travel, Accommodations, Expenses - Lilly; Roche Pharma AG
 
Jiri Zavadil
No Relationships to Disclose
 
Christian Brambilla
No Relationships to Disclose
 
Magali Olivier
No Relationships to Disclose
 
Sebastien Couraud
Stock and Other Ownership Interests - E Formed
Honoraria - AstraZeneca; Boehringer Ingelheim; Lilly; MSD; Roche
Consulting or Advisory Role - Boehringer Ingelheim; Lilly; Roche
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Lilly (Inst); Pfizer (Inst); Pierre Fabre (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Chiesi; Lilly; Pfizer; Roche